Ticker Appearances
Technical Strategy
AAPL, GOOGL, NFLX breakouts help to aid "Mag 7" in the short run
NEAR-TERM TRENDS ARE BULLISH FOR SPX AND I ANTICIPATE A SHARP RALLY TO FINISH THE MONTH OF OCTOBER AFTER AN INTERESTING PERIOD OF SECTOR ROTATION...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Daily Technical Strategy
Are the Defensives coming back to life?
SPX AND QQQ AT NEW ALL-TIME HIGH TERRITORY HAS NOT YET BEEN FOLLOWED BY SIMILAR MOVEMENT FROM RUSSELL 3K, VALUE LINE AVERAGE, AND DJ TRANSPORTATION...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Trick Or Treat from the FOMC? Equity rally will accelerate short-term if early Oct. lows are recouped
SPX AND QQQ VERY WELL COULD HAVE BOTTOMED LAST FRIDAY ON A PERFECT 3-MONTH ANNIVERSARY TO THE PEAKS FROM LATE JULY. HOWEVER, AS DISCUSSED IN...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Treasury Yield and US Dollar decline directly coincided with US Equity gains
Looking back at the start of October, we’ve seen a very nice kickoff to Q4, and almost too nice of a start following over a...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Short-term Bounce underway into next week
A short-term bounce looks to be underway in US Equities that likely carries prices higher into 9/14 and should reach at least 4125-4150. Following a...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Signal From Noise
Healthcare Showing Promise: Why We’re Bullish
Healthcare conversations over the past two years have centered almost exclusively on COVID-19, vaccinations, and therapeutics. Yet the dynamic sector offers much more to dissect...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
Buy Pharma, & Medical Distributor stocks
SPX and QQQ look to be bottoming near initial support after recent weakness.Healthcare looks to be breaking back out vs SPX in relative terms.Pharmaceutical stocks,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
Small caps start to lag again, while Equity Put call ratio hits lowest levels of the year
SPX and QQQ rally stalled out but no evidence of trend change by 3/30 close. Consolidation is more likely than not over the next 2...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
AAPL, GOOGL, NFLX breakouts help to aid "Mag 7" in the short run
NEAR-TERM TRENDS ARE BULLISH FOR SPX AND I ANTICIPATE A SHARP RALLY TO FINISH THE MONTH OF OCTOBER AFTER AN INTERESTING PERIOD OF SECTOR ROTATION...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Daily Technical Strategy
Are the Defensives coming back to life?
SPX AND QQQ AT NEW ALL-TIME HIGH TERRITORY HAS NOT YET BEEN FOLLOWED BY SIMILAR MOVEMENT FROM RUSSELL 3K, VALUE LINE AVERAGE, AND DJ TRANSPORTATION...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Trick Or Treat from the FOMC? Equity rally will accelerate short-term if early Oct. lows are recouped
SPX AND QQQ VERY WELL COULD HAVE BOTTOMED LAST FRIDAY ON A PERFECT 3-MONTH ANNIVERSARY TO THE PEAKS FROM LATE JULY. HOWEVER, AS DISCUSSED IN...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Treasury Yield and US Dollar decline directly coincided with US Equity gains
Looking back at the start of October, we’ve seen a very nice kickoff to Q4, and almost too nice of a start following over a...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Short-term Bounce underway into next week
A short-term bounce looks to be underway in US Equities that likely carries prices higher into 9/14 and should reach at least 4125-4150. Following a...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Signal From Noise
Healthcare Showing Promise: Why We’re Bullish
Healthcare conversations over the past two years have centered almost exclusively on COVID-19, vaccinations, and therapeutics. Yet the dynamic sector offers much more to dissect...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
Buy Pharma, & Medical Distributor stocks
SPX and QQQ look to be bottoming near initial support after recent weakness.Healthcare looks to be breaking back out vs SPX in relative terms.Pharmaceutical stocks,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
Small caps start to lag again, while Equity Put call ratio hits lowest levels of the year
SPX and QQQ rally stalled out but no evidence of trend change by 3/30 close. Consolidation is more likely than not over the next 2...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
AAPL, GOOGL, NFLX breakouts help to aid "Mag 7" in the short run
NEAR-TERM TRENDS ARE BULLISH FOR SPX AND I ANTICIPATE A SHARP RALLY TO FINISH THE MONTH OF OCTOBER AFTER AN INTERESTING PERIOD OF SECTOR ROTATION...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
